Health
Why Speed Isn't Everything: New Insights into Targeted Covalent Inhibitors
2025-08-22
Author: Daniel
Unlocking the Potential of Targeted Covalent Inhibitors (TCIs)
In the quest for effective treatments for diseases like lung cancer and COVID-19, targeted covalent inhibitors (TCIs) have emerged as a promising class of drugs. These innovative small molecules form strong covalent bonds with specific target proteins, enabling them to effectively inhibit their activity.
Brasil (PT)
Canada (EN)
Chile (ES)
Česko (CS)
대한민국 (KO)
España (ES)
France (FR)
Hong Kong (EN)
Italia (IT)
日本 (JA)
Magyarország (HU)
Norge (NO)
Polska (PL)
Schweiz (DE)
Singapore (EN)
Sverige (SV)
Suomi (FI)
Türkiye (TR)
الإمارات العربية المتحدة (AR)